Skip to main content

Table 4 Comparison of tumor factors between the PCA-NH group and the PCA-H group

From: Factors affecting sufentanil consumption for intravenous controlled analgesia after hepatectomy: retrospective analysis

 

PCA-NH (n = 428)

PCA-H (n = 134)

P-value

n (%)

Median (IQR)

n (%)

Median (IQR)

Tumor number

 Solitary

371 (75.6)

 

120 (24.4)

 

0.383

 Multiple

57 (80.3)

 

14 (19.7)

  

 Tumor’s size (cm)

 

3.20 (2.00, 5.00)

 

3.05 (2.04, 4.60)

0.522

Cut margin

 Free

407 (76.5)

 

125 (23.5)

 

0.416

 Infiltrated

21 (70.0)

 

9 (30.0)

  

Differentiation

 Well or moderate

323 (77.3)

 

95 (22.7)

 

0.142

 Poor

100 (72.5)

 

38 (27.5)

  

Vascular invasion

 No

386 (76.9)

 

116 (23.1)

 

0.236

 Yes

42 (70.0)

 

18 (30.0)

  

lymph nodes infiltration

 No

342 (76.7)

 

104 (23.3)

 

0.567

 Yes

86 (74.1)

 

30 (25.9)

  
  1. *P value < 0.05 statistically significant; Mann-Whitney U test; Chi-square test; n (%) = number (percentage).
  2. PCA-H High PCA sufentanil dosage, PCA-NH Non high PCA sufentanil dosage